Ursprung des Netzwerks ersten Grades von Yi Peng Qiu
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Industrial Machinery | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Yi Peng Qiu
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Tianjin University | College/University | Undergraduate Degree | |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| JOINTO ENERGY INVESTMENT CO., LTD. HEBEI | Electric Utilities | Director/Board Member | |
| HUMANWELL HEALTHCARE (GROUP) CO.,LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Nankai University | College/University | Masters Business Admin | |
| SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Beijing Eastern Chieftain Technology Co., Ltd. | Director/Board Member | ||
| DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
Hangzhou Shangjian Biotechnology Co., Ltd.
 Hangzhou Shangjian Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Shangjian Biotechnology Co., Ltd. is a company that develops, manufactures, and markets therapeutic antibody drugs and antibodies. The company is based in Hangzhou, China. The Chinese company was founded in 2015 by Ming Lu, who has been the CEO since 2015. | Pharmaceuticals: Major | Director/Board Member | |
Shanghai Haihe Biopharma Co., Ltd.
 Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Director/Board Member | |
Dizal Pharma
 Dizal Pharma BiotechnologyHealth Technology Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang. | Biotechnology | Director/Board Member | |
Beijing Liweite Investment Co., Ltd.
 Beijing Liweite Investment Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing Liweite Investment Co., Ltd. provides business services. Beijing Liweite Investment Co., Ltd. is based in Beijing, China. The Chinese company was founded in 2009. The CEO is Xue Xian Liang. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
| China | 13 |
Sektoral
| Health Technology | 6 |
| Commercial Services | 4 |
| Consumer Services | 3 |
| Utilities | 2 |
Operativ
| Director/Board Member | 19 |
| Independent Dir/Board Member | 8 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Investor Relations Contact | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Xue Gong Wang | 9 |
| Di Liu | 3 |
| Qiang Zhao | 3 |
| Jian Wang | 1 |
| You Lin Gu | 1 |
| Wen Yong Zhu | 1 |
| Yi Liang | 1 |
| Ya Dong Xu | 1 |
| Zhen Hua Lu | 1 |
- Börse
- Insiders
- Yi Peng Qiu
- Unternehmensverbindungen
